Skip to main content Back to Top

Drug Pricing in Transition: What’s Ahead for 340B and the IRA

Broadcast Date: November 18, 2026


ABOUT THIS PODCAST

Congress and federal agencies are considering significant changes to the 340B program, while implementation of the Inflation Reduction Act’s Medicare drug price negotiation provisions continues to raise important questions for hospitals and health systems. We’ll provide an update on the latest legislative and regulatory developments, the intersection of IRA implementation and the HRSA 340B rebate pilot, and what to expect from Congress and federal agencies in the months ahead.

SPEAKERS

  • Frank Kolb, JD, MPH
    Director, Federal Legislative Affairs
    ASHP
  • Jillanne Schulte Wall, JD
    Senior Director, Health & Regulatory Policy
    ASHP
  • Tom Kraus, JD
    Chief Advocacy Officer and Vice President, Government Relations
    ASHP

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.